News Announcement

Biocon: Announcement under Regulation 30 (LODR)-Change in Directorate

In continuation to our letter dated October 23 2019 titled Change in Directorate and Key Managerial Personnel (KMP) please find enclosed the resignation letter along with confirmation received from Dr. Jeremy Levin pursuant to Regulation 30 read with Schedule III - Part A - Part A - Clause 7B of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.